Mind

MindMed is a clinical-stage biopharmaceutical company focused on developing novel products to treat brain health disorders, with a particular emphasis on the use of psychedelic-inspired medicines. The company's pipeline includes candidates targeting generalized anxiety disorder, major depressive disorder, and ADHD, utilizing substances such as LSD and 18-MC. MindMed aims to address significant unmet needs in psychiatry and addiction by leveraging a deep understanding of the mechanisms of action of psychedelic compounds. Through its clinical programs, the company is advancing a new class of therapies designed to provide long-lasting relief for patients suffering from complex mental health conditions.